Skip to main content
Top
Published in: CardioVascular and Interventional Radiology 12/2017

01-12-2017 | Clinical Investigation

Magnetic Resonance Signal Intensity Ratio Measurement Before Uterine Artery Embolization: Ability to Predict Fibroid Size Reduction

Authors: Stevo Duvnjak, Pernille Ravn, Anders Green, Poul Erik Andersen

Published in: CardioVascular and Interventional Radiology | Issue 12/2017

Login to get access

Abstract

Purpose

To evaluate whether the magnetic resonance imaging (MRI) signal intensity (SI) ratio between the dominant fibroid and the periphery striated muscle can predict fibroid volume reduction >50% after uterine fibroid embolization (UFE).

Materials and Methods

From October 2013 until May 2016, 52 patients were included in this prospective study. The SI ratio before UFE was calculated using circular region of interests placed on the dominant fibroid and the iliac muscle. The SI fibroid-to-iliac muscle ratio was calculated as SI of the dominant fibroid/SI of the iliac muscle on T1-, T2-, and T1 post-contrast-weighted sequences. The dominant fibroid volume was measured and analyzed before and after UFE.

Results

In all, 46 patients who completed the three-month follow-up MRI were available for analysis. The correlation between SI fibroid-to-muscle ratio at the T2-weighted sequence and imaging volume reduction outcome was statistically significant (p < 0.002). All other parameters showed no statistically significant reduction in fibroid volume: (p < 0.68) for SI ratio at T1-weighted, (p < 0.13) for SI ratio at T1 post-contrast, and (p < 0.58) for fibroid volume. Spearman’s rank showed positive correlation (r = 0.439, p < 0.003) between the fibroid-to-muscle SI ratio on T2-weighted sequence. The area under curve (AUC) for SI fibroid-to-muscle ratio on T2-weighted sequence was 0.776. For the other parameters, the AUC values were 0.512, 0.671, and 0.578, respectively.

Conclusion

SI dominant fibroid-to-muscle ratio at T2-weighted sequence before UFE was significantly related to dominant fibroid volume reduction after UFE and may be used for better patient selection.
Literature
1.
go back to reference VerKauf BS. Changes trends in treatment of leiomyoma uteri. Curr Opin Obstet Gyncol. 1993;5:301–10. VerKauf BS. Changes trends in treatment of leiomyoma uteri. Curr Opin Obstet Gyncol. 1993;5:301–10.
2.
go back to reference Worthington-Kirsch RL, Popky GL, Hutchins FL Jr. Uterine arterial embolization for the management of leiomyomas: quality of life assessment and clinical response. Radiology. 1998;208:625–9.CrossRefPubMed Worthington-Kirsch RL, Popky GL, Hutchins FL Jr. Uterine arterial embolization for the management of leiomyomas: quality of life assessment and clinical response. Radiology. 1998;208:625–9.CrossRefPubMed
3.
go back to reference Spies JB, Bruno J, Czeyda-Pommersheim F, Magee ST, Ascher SA, Jha RC. Long-term outcome of uterine artery embolization of leiomyomata. Obstet Gynecol. 2005;106:933–9.CrossRefPubMed Spies JB, Bruno J, Czeyda-Pommersheim F, Magee ST, Ascher SA, Jha RC. Long-term outcome of uterine artery embolization of leiomyomata. Obstet Gynecol. 2005;106:933–9.CrossRefPubMed
4.
go back to reference Deshmukh SP, Gonsalves CF, Guglielmo FF, et al. Role of MR imaging of uterine leiomyomas before and after embolization. Radiographics. 2012;32(6):E251–81.CrossRefPubMed Deshmukh SP, Gonsalves CF, Guglielmo FF, et al. Role of MR imaging of uterine leiomyomas before and after embolization. Radiographics. 2012;32(6):E251–81.CrossRefPubMed
5.
go back to reference Jha RC, Ascher SM, Imaoka I, Spies JB. Symptomatic fibroleiomyomata: MR imaging of the uterus before and after uterine arterial embolization. Radiology. 2000;217:228–35.CrossRefPubMed Jha RC, Ascher SM, Imaoka I, Spies JB. Symptomatic fibroleiomyomata: MR imaging of the uterus before and after uterine arterial embolization. Radiology. 2000;217:228–35.CrossRefPubMed
6.
go back to reference Sipola P, Ruuskanen A, Yawu L, et al. Preinterventional quantitative magnetic resonance imaging predicts uterus and leiomyoma size reduction after uterine artery embolization. J Magn Reson Imaging. 2010;31:617–24.CrossRefPubMed Sipola P, Ruuskanen A, Yawu L, et al. Preinterventional quantitative magnetic resonance imaging predicts uterus and leiomyoma size reduction after uterine artery embolization. J Magn Reson Imaging. 2010;31:617–24.CrossRefPubMed
7.
go back to reference Faye N, Pellerin O, Thiam R, et al. Diffusion-weighted imaging for evaluation of uterine arterial embolization of fibroids. Magn Reson Med. 2013;70:1739–47.CrossRefPubMed Faye N, Pellerin O, Thiam R, et al. Diffusion-weighted imaging for evaluation of uterine arterial embolization of fibroids. Magn Reson Med. 2013;70:1739–47.CrossRefPubMed
8.
go back to reference Harman M, Zeteroglu S, Arslan H, et al. Predictive value of magnetic resonance imaging signal and contrast-enhancement characteristics on postembolization volume reduction of uterine fibroids. Acta Radiol. 2006;47:427–35.CrossRefPubMed Harman M, Zeteroglu S, Arslan H, et al. Predictive value of magnetic resonance imaging signal and contrast-enhancement characteristics on postembolization volume reduction of uterine fibroids. Acta Radiol. 2006;47:427–35.CrossRefPubMed
9.
go back to reference Duvnjak S, Ravn P, Green A, Andersen PE. Uterine fibroid embolization with acrylamido polyvinyl microspheres: prospective 12-month clinical and MRI follow-up study. Acta Radiol 2016. doi:10.1177/0284185116679458. Duvnjak S, Ravn P, Green A, Andersen PE. Uterine fibroid embolization with acrylamido polyvinyl microspheres: prospective 12-month clinical and MRI follow-up study. Acta Radiol 2016. doi:10.​1177/​0284185116679458​.
10.
go back to reference Pelage JP, Guaou NG, Jha RC, Ascher SM, Spies JB. Uterine fibroid tumors: long-term MR imaging outcome after embolization. Radiology. 2004;230:803–9.CrossRefPubMed Pelage JP, Guaou NG, Jha RC, Ascher SM, Spies JB. Uterine fibroid tumors: long-term MR imaging outcome after embolization. Radiology. 2004;230:803–9.CrossRefPubMed
11.
go back to reference Kroencke TJ, Scheuring C, Lampmann LE, et al. Acrylamido polyvinyl alcohol microspheres for uterine artery embolization: 12-month clinical and MR imaging results. J Vasc Interv Radiol. 2008;19:47–57.CrossRefPubMed Kroencke TJ, Scheuring C, Lampmann LE, et al. Acrylamido polyvinyl alcohol microspheres for uterine artery embolization: 12-month clinical and MR imaging results. J Vasc Interv Radiol. 2008;19:47–57.CrossRefPubMed
12.
go back to reference Hald K, Noreng HJ, Istre O, Klow NE. Uterine artery embolization versus laparoscopic occlusion of uterine arteries for leiomyomas: long-term results of a randomized comparative trial. J Vasc Interv Radiol. 2009;20:1303–10.CrossRefPubMed Hald K, Noreng HJ, Istre O, Klow NE. Uterine artery embolization versus laparoscopic occlusion of uterine arteries for leiomyomas: long-term results of a randomized comparative trial. J Vasc Interv Radiol. 2009;20:1303–10.CrossRefPubMed
13.
go back to reference Toor SS, Tan KT, Simons ME, et al. Clinical failure after uterine artery embolization: evaluation of patient and MR imaging characteristics. J Vasc Interv Radiol. 2008;19(5):662–7.CrossRefPubMed Toor SS, Tan KT, Simons ME, et al. Clinical failure after uterine artery embolization: evaluation of patient and MR imaging characteristics. J Vasc Interv Radiol. 2008;19(5):662–7.CrossRefPubMed
14.
go back to reference Lee MS, Kim MD, Chung DC, et al. Apparent diffusion coefficient of uterine leiomyoma as a predictor of the potential response to uterine artery embolization. J Vasc Interv Radiol. 2013;24(9):1361–5.CrossRefPubMed Lee MS, Kim MD, Chung DC, et al. Apparent diffusion coefficient of uterine leiomyoma as a predictor of the potential response to uterine artery embolization. J Vasc Interv Radiol. 2013;24(9):1361–5.CrossRefPubMed
15.
go back to reference Burn PR, McCall JM, Chinn RJ, et al. Uterine fibroleiomyoma: MR imaging appearances before and after embolization of uterine arteries. Radiology. 2000;214(3):729–34.CrossRefPubMed Burn PR, McCall JM, Chinn RJ, et al. Uterine fibroleiomyoma: MR imaging appearances before and after embolization of uterine arteries. Radiology. 2000;214(3):729–34.CrossRefPubMed
16.
go back to reference deSouza N, Williams A. Uterine arterial embolization for leiomyomas: perfusion and volume changes at MR imaging and relation to clinical outcome. Radiology. 2002;222(2):367–74.CrossRefPubMed deSouza N, Williams A. Uterine arterial embolization for leiomyomas: perfusion and volume changes at MR imaging and relation to clinical outcome. Radiology. 2002;222(2):367–74.CrossRefPubMed
17.
go back to reference Watson G, Walker W. Uterine artery embolisation for the treatment of symptomatic fibroids in 114 women: reduction in size of the fibroids and women’s views of the success of the treatment. BJOG. 2002;109(2):129–35.CrossRefPubMed Watson G, Walker W. Uterine artery embolisation for the treatment of symptomatic fibroids in 114 women: reduction in size of the fibroids and women’s views of the success of the treatment. BJOG. 2002;109(2):129–35.CrossRefPubMed
18.
go back to reference Jain T, Srivastava D, Sahu R, et al. Uterine artery embolization for symptomatic fibroids with imaging follow up. Australas Radiol. 2007;51(3):246–52.CrossRefPubMed Jain T, Srivastava D, Sahu R, et al. Uterine artery embolization for symptomatic fibroids with imaging follow up. Australas Radiol. 2007;51(3):246–52.CrossRefPubMed
19.
go back to reference Hecht EM, Do RK, Kang SK, Bennett GL, Babb JS, Clark TI. Diffusion-weighted imaging for prediction of volumetric response of leiomyomas following uterine artery embolization: a preliminary study. J Magn Reson Imaging. 2011;33:641–6.CrossRefPubMed Hecht EM, Do RK, Kang SK, Bennett GL, Babb JS, Clark TI. Diffusion-weighted imaging for prediction of volumetric response of leiomyomas following uterine artery embolization: a preliminary study. J Magn Reson Imaging. 2011;33:641–6.CrossRefPubMed
20.
go back to reference Yamashita Y, Torashima M, Takahashi M, et al. Hyperintense uterine leiomyoma at T2-weighted MR imaging: differentiation with dynamic enhanced MR imaging and clinical implications. Radiology. 1993;189:721–5.CrossRefPubMed Yamashita Y, Torashima M, Takahashi M, et al. Hyperintense uterine leiomyoma at T2-weighted MR imaging: differentiation with dynamic enhanced MR imaging and clinical implications. Radiology. 1993;189:721–5.CrossRefPubMed
21.
go back to reference Spies JB, Ascher SA, Roth AR, et al. Uterine artery embolization for leiomyomata. Obstet Gynecol. 2001;98(1):29–34.PubMed Spies JB, Ascher SA, Roth AR, et al. Uterine artery embolization for leiomyomata. Obstet Gynecol. 2001;98(1):29–34.PubMed
22.
go back to reference Katsumori T, Akazawa K, Mihara T. Uterine artery embolization for pedunculated subserosal fibroids. AJR Am J Roentgenol. 2005;184(2):399–402.CrossRefPubMed Katsumori T, Akazawa K, Mihara T. Uterine artery embolization for pedunculated subserosal fibroids. AJR Am J Roentgenol. 2005;184(2):399–402.CrossRefPubMed
Metadata
Title
Magnetic Resonance Signal Intensity Ratio Measurement Before Uterine Artery Embolization: Ability to Predict Fibroid Size Reduction
Authors
Stevo Duvnjak
Pernille Ravn
Anders Green
Poul Erik Andersen
Publication date
01-12-2017
Publisher
Springer US
Published in
CardioVascular and Interventional Radiology / Issue 12/2017
Print ISSN: 0174-1551
Electronic ISSN: 1432-086X
DOI
https://doi.org/10.1007/s00270-017-1721-2

Other articles of this Issue 12/2017

CardioVascular and Interventional Radiology 12/2017 Go to the issue